Login / Signup

Identifying key factors contributing to treatment costs for snakebite envenoming in private tertiary healthcare settings in Tamil Nadu, India.

Anika SalimJarred WilliamsSamir Abdel WahabTade AdeshokanJosé Rafael AlmeidaHarry F WilliamsRajendran VaiyapuriSubramanian SenthilkumaranPonniah ThirumalaikolundusubramanianKetan PatelM Fazil BakshMatthew R LewinSakthivel Vaiyapuri
Published in: PLoS neglected tropical diseases (2023)
These data demonstrate that ~80% of snakebite patients can be treated with INR 100,000 (~GBP 1000 or USD 1200) or less. This study emphasises the urgent need to improve rural medical care by providing appropriate training for healthcare professionals and essential resources to facilitate early assessment of patients, administer the initial dose of antivenom and refer the patients to tertiary care only when needed. Moreover, the outcome of this study forms a basis for developing appropriate policies to regulate snakebite treatment costs and provide affordable medical insurance for vulnerable communities.
Keyphrases
  • healthcare
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • prognostic factors
  • peritoneal dialysis
  • public health
  • patient reported outcomes
  • machine learning
  • patient reported
  • artificial intelligence